GBC Raises NanoRepro Price Target to EUR 4.55 From EUR 4.50

• GBC reiterated its Buy rating on NanoRepro, raising its price target to EUR 4.55 per share from EUR 4.50.
• The target, set for December 31, 2027, reflects newkee’s full consolidation and lower capital costs, partly offset by higher startup losses.
• GBC forecasts 2026 revenue of EUR 18 million, with an EBITDA loss of EUR 1.5 million driven largely by integration-related costs.
• For 2027, analysts expect revenue of EUR 23.8 million and positive EBITDA of EUR 600,000, supported by newkee’s first full-year consolidation.
• EBITDA is projected to reach EUR 2.8 million in 2028, implying a 10% margin as synergies and improved capacity utilization lift profitability.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoRepro AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_27142) on October 21, 2026, and is solely responsible for the information contained therein.